Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Trebananib | Login | Research Grade Trebananib | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human PSCA Antibody (MK-4721) | Login | Research Grade Anti-Human PSCA Antibody (MK-4721) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human BTN3A1 (ICT 01) | Login | Research Grade Anti-Human BTN3A1 (ICT 01) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD203c/ENPP3 & CD3 (XmAb819) | Login | Research Grade Anti-Human CD203c/ENPP3 & CD3 (XmAb819) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human LRP6 (GSK3178022) | Login | Research Grade Anti-Human LRP6 (GSK3178022) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD205/LY75 (OX-002) | Login | Research Grade Anti-Human CD205/LY75 (OX-002) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human PSCA (AGS-1C4D4) | Login | Research Grade Anti-Human PSCA (AGS-1C4D4) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human PSCA (BPX-601) | Login | Research Grade Anti-Human PSCA (BPX-601) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human PSCA (GEM 3 PSCA) | Login | Research Grade Anti-Human PSCA (GEM 3 PSCA) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD254/RANKL/TNFSF11 (ALX-0141) | Login | Research Grade Anti-Human CD254/RANKL/TNFSF11 (ALX-0141) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD254/RANKL/TNFSF11 (GB223) | Login | Research Grade Anti-Human CD254/RANKL/TNFSF11 (GB223) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD254/RANKL/TNFSF11 (JHL1266) | Login | Research Grade Anti-Human CD254/RANKL/TNFSF11 (JHL1266) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD254/RANKL/TNFSF11 (MW032) | Login | Research Grade Anti-Human CD254/RANKL/TNFSF11 (MW032) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD254/RANKL/TNFSF11 (ONS-4010) | Login | Research Grade Anti-Human CD254/RANKL/TNFSF11 (ONS-4010) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human TWEAK/TNFSF12 (BIIB023) | Login | Research Grade Anti-Human TWEAK/TNFSF12 (BIIB023) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Oberotatug | Login | Research Grade Oberotatug | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ozekibart | Login | Research Grade Ozekibart | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD262/TNFRSF10B/DR5 Antibody (TAS266) | Login | Research Grade Anti-Human CD262/TNFRSF10B/DR5 Antibody (TAS266) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Povetacicept | Login | Research Grade Povetacicept | ||||||||||||||||
|
||||||||||||||||||
Research Grade Aplitabart | Login | Research Grade Aplitabart | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD255/TNFSF12/TWEAK Antibody (RO5458640/RG7212) | Login | Research Grade Anti-Human CD255/TNFSF12/TWEAK Antibody (RO5458640/RG7212) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human VEGFA & ANGPT2 Bispecific Antibody (BI836880) | Login | Research Grade Anti-Human VEGFA & ANGPT2 Bispecific Antibody (BI836880) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ziltivekimab | Login | Research Grade Ziltivekimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sirukumab | Login | Research Grade Sirukumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Olokizumab | Login | Research Grade Olokizumab | ||||||||||||||||
|